Clinical trials are vital for advancing medical knowledge, yet engaging diverse populations—those under-represented due to race, age, income, education, geography, sexual orientation, or gender identity—remains a challenge, limiting research generalizability.
Methods
This study used a literature review and semi-structured interviews with participants from diverse backgrounds recruited on LinkedIn. A demographic survey was conducted via Qualtrics, yielding 21 responses and 15 study participants. The research identified barriers to participation: inadequate community engagement, trial awareness, mistrust, and unaddressed social determinants of health, with data analyzed for key themes.
Results
Four themes emerged: (1) Community engagement builds trust; (2) Addressing social determinants alleviates barriers; (3) Peer education empowers participants; (4) A representative workforce enhances recruitment.
Discussion
Findings emphasize the necessity of inclusive practices in clinical research, highlighting that targeted strategies can improve diversity in clinical trials, leading to more equitable healthcare outcomes. Future research should refine these strategies in specific therapeutic areas.
ClarkL. T.WatkinsL.PiñaI. L.ElmerM.AkinboboyeO.GorhamM.JamersonB.McCulloughC.PierreC.PolisA. B.PuckreinG.RegnanteJ. M. (2019). Increasing diversity in clinical trials: Overcoming critical barriers. Current Problems in Cardiology, 44(5), 148–172. https://doi.org/10.1016/j.cpcardiol.2018.11.002
4.
DumaN.KothadiaS. M.AzamT. U.YadavS.PaludoJ.Vera AguileraJ.Gonzalez VelezM.HalfdanarsonT. R.MolinaJ. R.HubbardJ. M.GoR. S.MansfieldA. S.AdjeiA. A. (2019). Characterization of comorbidities limiting the recruitment of patients in early phase clinical trials. The Oncologist, 24(1), 96–102. https://doi.org/10.1634/theoncologist.2017-0687
HamelL. M.PennerL. A.AlbrechtT. L.HeathE.GwedeC. K.EgglyS. (2016). Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control, 23(4), 327–337. https://doi.org/10.1177/107327481602300404
MeyerS.WolduH. G.SheetsL. R. (2021). Sociodemographic diversity in cancer clinical trials: New findings on the effect of race and ethnicity. Contemporary Clinical Trials Communications, 21, 100718. https://doi.org/10.1016/j.conctc.2021.100718
14.
NASEM. (2022). Why diverse representation in clinical research matters and the current state of representation within the clinical research ecosystem. Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. https://www.ncbi.nlm.nih.gov/books/NBK584396/
O’BrienB. C.HarrisI. B.BeckmanT. J.ReedD. A.CookD. A. (2025). The SRQR reporting checklist. In HarwoodJ.AlburyC.BeyerJ. d.SchlüsselM.CollinsG. (Eds.), The EQUATOR network reporting guideline platform [Internet]. The UK EQUATOR Centre. Equator Network. Available from: https:/resources.equator-network.org/reporting-guidelines/srqr/srqr-checklist.docx
18.
O’BrienB. C.HarrisI. B.BeckmanT. J.ReedD. A.CookD. A. (September 2014). Standards for reporting qualitative research: A synthesis of recommendations. Academic Medicine, 89(9), 1245–1251. https://doi.org/10.1097/ACM.0000000000000388
19.
OdedinaF. T.WielandM. L.Barbel-JohnsonK.CrookJ. M. (2024). Community engagement strategies for underrepresented racial and ethnic populations. Mayo Clinic Proceedings, 99(1), 159–171. https://doi.org/10.1016/j.mayocp.2023.07.015
20.
OtadoJ.KwagyanJ.EdwardsD.UkaegbuA.RockcliffeF.OsafoN. (2015). Culturally competent strategies for recruitment and retention of African American populations into clinical trials. Clinical and Translational Science, 8(5), 460–466. https://doi.org/10.1111/cts.12285
21.
RoyE.ChinoF.KingB.MaduC.MattesM.MorrellR.Pollard-LarkinJ.SikerM.TakitaC.LudwigM. (2023). Increasing diversity of patients in radiation oncology clinical trials. International Journal of Radiation Oncology*Biology*Physics, 116(1), 103–114. https://doi.org/10.1016/j.ijrobp.2022.11.044
StantonR. J.AzizY. N.SucharewH.HaverbuschM.RobinsonD. J.ColemanE.De Los Rios La RosaF.DemelS.FerioliS.MackeyJ.JasneA.MadsenT. E.MistryE.SlavinS.StarM.WalshK.WooD.KhatriP.BroderickJ.KleindorferD. O. (2024). Clinical trial exclusion criteria affect trial inclusivity by race and sex. Journal of the American Heart Association, 13(13), e035102. https://doi.org/10.1161/JAHA.124.035102
24.
StudnaA. (2025). Clinical Research, DEI Initiatives Caught in Political Headwinds Amidst Funding Freeze. Applied Clinical Trials. Published February13, 1.
25.
VaughnV. M.HorowitzJ.GandhiT.NeetzR. A.PettyL.HershA.LindenauerP.BernsteinS. J.FlandersS. A.HarrisonJ. D.SmithJ. D.WhiteA. T.SzymczakJ. E. (2025). Developing an approach to enhance recruitment for a cluster-randomised implementation trial: Leveraging deliberative participation and credible messengers. BMJ Open, 15(9), 3–10. https://doi.org/10.1136/bmjopen-2024-094925
WinterS. S.Page-ReevesJ. M.PageK. A.HaozousE.SolaresA.CordovaN.LarsonC.SR. (2018). Inclusion of special populations in clinical research: Important considerations and guidelines. Journal Of Clinical And Translational Research, 4(1), 56–69. https://doi.org/10.18053/jctres.04.201801.003
Woods-BurnhamL.JohnsonJ. R.HookerS. E.BedellF. W.DorffT. B.KittlesR. A. (2021). The role of diverse populations in US clinical trials. Med, 2(1), 21–24. https://doi.org/10.1016/j.medj.2020.12.009
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
